NetworkNewsBreaks

WednesdayJan 11, 2017 2:30 pm

NetworkNewsBreaks – Sangamo Therapeutics, Inc. (NASDAQ: SGMO): FDA Grants Orphan Drug Designation for SB-318

Sangamo Therapeutics (NASDAQ: SGMO) is trading higher this morning on news the U.S. Food and Drug Administration (FDA) has granted Orphan Drug Designation to the company’s SB-318, a genome editing product candidate for the treatment of Mucopolysaccharidosis Type I (MPS I), a rare lysosomal storage disorder. The FDA grants orphan drug designation to drugs and biologics intended to treat rare diseases, providing incentives to advance development of rare disease drugs as well as commercialization of drugs that progress to approval. Sangamo also noted its plans to “conduct the first ever in vivo genome editing clinical trials including Phase 1/2 studies…

Continue Reading

TuesdayJan 10, 2017 3:01 pm

NetworkNewsBreaks – Top 10 Mid-day Percentage Gainers on January 10, 2017

Here is a list of stocks shaking up the markets today, with particular focus on NASDAQ and OTC small caps. The top gainers based on percentage: DSGT 75.00% – News: Presenting product line at 2017 PGA Merchandise Show in Orlando XGTI 17.31% – News: Regains Nasdaq listing compliance CMXC 16.67% – News: Reports positive observational results of trial in Manila, Philippines KAYS 16.49% – News:  Receives full recreational marijuana retailer license from OLCC for South Salem Kaya Shack™; secures $2.1M funding commitment HPCQ 15.00% – News: Enters exclusive distributor agreement for Guatemala with Fertica Group TENG 14.75%– News: Advisement from…

Continue Reading

TuesdayJan 10, 2017 3:01 pm

NetworkNewsBreaks – Biocept, Inc. (NASDAQ: BIOC) Shares Surge on Coverage Agreement with Blue Cross Blue Shield of Texas

Shares of Biocept (NASDAQ: BIOC) are up 15% on word the molecular diagnostics company has obtained an in-network provider agreement with Blue Cross Blue Shield of Texas (BCBSTX). The company views the achievement as a milestone in expanding coverage for its Target Selector™ platform, as BCBSTX is the largest provider of health benefits in Texas. "Partnering with health insurers is a major focus of our business strategy, as it may increase physician access to this non-invasive technology for their patients and provide timely adjudication of claims for patients. Securing this in-network agreement is an important milestone for Biocept, as Texas…

Continue Reading

TuesdayJan 10, 2017 2:36 pm

NetworkNewsBreaks – Arcadia Biosciences, Inc. (NASDAQ: RKDA) Receives U.S. FDA GRAS Status for SONOVA® GLA Safflower Oil, Expands Application Options

Arcadia Biosciences (NASDAQ: RKDA) this morning announced that the U.S. Food and Drug Administration (FDA) has accepted the company’s conclusion that its SONOVA® GLA safflower oil is “generally recognized as safe” (GRAS) for use in nutritional beverages and medical foods. The company followed FDA-proposed procedures to establish its SONOVA® GLA (gamma-linolenic acid) safflower oil as GRAS under the intended conditions of use as a nutritional supplement product. “This FDA GRAS notification expands the application options for Arcadia’s SONOVA® GLA safflower oil, opening adjacent markets for our customers in nutritional beverages and medical foods,” president and CEO Raj Ketkar stated in…

Continue Reading

TuesdayJan 10, 2017 1:25 pm

NetworkNewsBreaks – Pluristem (NASDAQ: PSTI) Receives FDA Clearance for Phase 3 PLX-PAD Cells Study; Shares Higher

Shares of Pluristem Therapeutics (NASDAQ: PSTI) are up 7% mid-morning following news that the FDA has cleared the company’s phase 3 study of its PLX-PAD cells in the treatment of critical limb ischemia (CLI). Patients with CLI are at an immediate risk for limb amputation and death, and with meager treatment options, have a severe unmet medical need. The company said it intends to use the results of its study to submit a biologics license application to the FDA for marketing approval. The study is expected to begin patient enrollment in both the U.S. and Europe by June 2017.  “We…

Continue Reading

MondayJan 09, 2017 1:00 pm

NetworkNewsBreaks – Top 10 Mid-day Percentage Gainers on January 9, 2017

Here is a list of stocks shaking up the markets today, with particular focus on NASDAQ and OTC small caps. The top gainers based on percentage: VPRB 12.50% – News: Names new COO VBIO 12.31% – News: Presenting at Biotech Showcase on January 11 in San Francisco CMXC 12.00% – News: Received the first eBalance Pro wellness devices SINO 10.16% – News: Enters joint venture agreement with Jetta Global Logistics RAVE 10.01% – News: Names new CEO APOP 7.69%– News: Major shareholder increases holdings CRNT 6.87% – News: Posts Q4 2016 financial results IMII 6.59% – News: Releases additional data…

Continue Reading

MondayJan 09, 2017 12:58 pm

NetworkNewsBreaks – Medical Marijuana, Inc. (MJNA) Reports Positive Data on CanChew Plus® CBD Gum by AXIM® Biotechnologies, Inc. (AXIM)

Shares of Medical Marijuana (OTC: MJNA) are ticking higher after the company said its major investment company, AXIM® Biotechnologies (OTC: AXIM), received positive pharmacokinetic (PK) data results on its CanChew Plus® CBD Gum, which will be used in upcoming clinical trials as treatment for irritable bowel syndrome (IBS). The single dose study conducted to determine the concentration of CBD in the blood after chewing one CanChew Plus® Gum for 30 minutes showed positive results for the 30 mg dosage. This data will be used to determine the optimal concentration in the IBS patient trial. AXIM aims to provide a pharmaceutical…

Continue Reading

MondayJan 09, 2017 12:54 pm

NetworkNewsBreaks – DryShips, Inc. (NASDAQ: DRYS) Acquires Large Gas Carrier through Option Agreement; Delivery set for June 2017

DryShips (NASDAQ: DRYS) has exercised its first option under a previously announced option agreement to acquire one Very Large Gas Carrier (VLGC) currently under construction at Hyundai Heavy Industries (HHI) for a purchase price of $83.5 million. The VLGC will be employed on a fixed-rate time charter with five years’ firm duration to an oil major; the charterer has options to extend the firm employment period by up to three years. DryShips said it expects the total gross backlog associated with this time charter to be $54.0 million – or $92.7 million including the optional periods – with delivery of…

Continue Reading

FridayJan 06, 2017 1:50 pm

NetworkNewsBreaks – Top 10 Mid-day Percentage Gainers on January 6, 2017

Here is a list of stocks shaking up the markets today, with particular focus on NASDAQ and OTC small caps. The top gainers based on percentage: RSPI 12.07% – News: To present at 9th Annual Biotech Showcase January 9 PSCR 8.42% – News: Details multi-year contract with Centers for Medicare and Medicaid Services TYMI 7.97% – News: Hires Shabnam Stanicky as clinical operations officer ARDM 4.75% – News: To present at 9th Annual Biotech Showcase January 9 FHCO 2.52%– News: Launches PREBOOST for premature ejaculation SGMO 3.62% – News: Changes name to Sangamo Therapeutics to reflect focus on clinical development of…

Continue Reading

FridayJan 06, 2017 1:45 pm

NetworkNewsBreaks – Revance Therapeutics, Inc. (NASDAQ: RVNC) Flags Clinical Milestones, Offers 2017 Financial Guidance

Revance Therapeutics (NASDAQ: RVNC) has three ongoing clinical trials of its RT002 injectable, the results of which the company says it will report by year-end. In a news release yesterday afternoon, the company also guided for 2017 cash burn between $102 million-$112 million; GAAP operating expense between $108 million-$119 million; and non-GAAP operating expense of $94 million-$102 million. R&D expense for 2017 is forecast in the range of $75 million-$83 million (GAAP), $69 million-$75 million (non-GAAP).  Revance’s cash and investments balance of $185 million, as of Dec. 31, 2016, is expected to fund operations into the third quarter of 2018.…

Continue Reading